Adenosquamous carcinoma of the lung

被引:73
|
作者
Li, Chenghui [1 ,2 ]
Lu, Hongyang [2 ,3 ]
机构
[1] Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Dept Thorac Med Oncol, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Canc Hosp, Zhejiang Key Lab Diag & Treatment Technol Thorac, 1 East Banshan Rd, Hangzhou 310022, Zhejiang, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2018年 / 11卷
关键词
adenosquamous carcinoma of the lung; clinicopathological characteristics; histogenesis; prognosis; chemotherapy; targeted therapy; immunotherapy; SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; THYMIDYLATE-SYNTHASE; 1ST-LINE TREATMENT; OPEN-LABEL; MUTATIONS; EGFR; ADENOCARCINOMA; CANCER;
D O I
10.2147/OTT.S164574
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Adenosquamous carcinoma of the lung (ASC), a relatively rare subtype of non-small-cell lung cancer, is defined as a malignancy containing components of lung adenocarcinoma (ADC) and lung squamous cell carcinoma (SCC). Although ASC has biological characteristics of ADC and SCC, it is not by any means a simple hybrid of two components above. It is extremely difficult to diagnose preoperatively; pathology of surgically resected gross specimen is the most effective means for adequate diagnosis of ASC. Platinum-based postoperative adjuvant chemotherapy for at least four cycles can significantly improve the survival in stage III patients with ASC. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) such as erlotinib and gefitinib can be the effective therapeutic strategies for advanced EGFRmutant ASC. The studies of crizotinib in the treatment of patients with ASC are very limited. Immune checkpoint blockade therapy may be a potential treatment choice for ASC patients.
引用
收藏
页码:4829 / 4835
页数:7
相关论文
共 50 条
  • [41] Survival analysis for lung adenosquamous carcinoma patients with brain metastasis
    Pan, Feng
    Cui, Shaohua
    Wang, Weimin
    Gu, Aiqin
    Jiang, Liyan
    JOURNAL OF CANCER, 2018, 9 (20): : 3707 - 3712
  • [42] ADENOSQUAMOUS LUNG-CARCINOMA - CLINICAL CHARACTERISTICS, TREATMENT, AND PROGNOSIS
    NAUNHEIM, KS
    TAYLOR, JR
    SKOSEY, C
    HOFFMAN, PC
    FERGUSON, MK
    GOLOMB, HM
    LITTLE, AG
    ANNALS OF THORACIC SURGERY, 1987, 44 (05): : 462 - 466
  • [43] Genomic Evidence Depicting Clonal Evolution of Lung Adenosquamous Carcinoma
    Han, Y.
    Lu, S.
    Zhao, R.
    Xu, Y.
    Chen, Y.
    Xiang, C.
    Wu, Q.
    Chen, S.
    Pang, J.
    Shang, Z.
    Zhao, J.
    Bao, H.
    Shao, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S609 - S609
  • [44] Reply to “EGFR Mutation in Patients with Lung Adenosquamous Cell Carcinoma”
    Yosuke Morodomi
    Tatsuro Okamoto
    Yoshihiko Maehara
    Annals of Surgical Oncology, 2017, 24 : 676 - 676
  • [45] Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung
    Shu, Catherine
    Cheng, Haiying
    Wang, Antai
    Mansukhani, Mahesh M.
    Powell, Charles A.
    Halmos, Balazs
    Borczuk, Alain C.
    MODERN PATHOLOGY, 2013, 26 (02) : 239 - 246
  • [46] Growing spheroids of lung adenosquamous carcinoma on electrospun poly(ε-caprolactone)
    Gonzalez-Martinez, Eduardo
    Ramon Diaz-Aguila, Carlos
    Cruz Rodriguez, Mabel
    Sanchez Ramirez, Belinda
    de Lourdes Albor-Aguilera, Maria
    Gonzalez Alfaro, Yorexis
    Yee-Madeira, Hernani
    BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS, 2020, 9 (04) : 252 - 256
  • [47] EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung
    Jia, Xiao-Li
    Chen, Gang
    LUNG CANCER, 2011, 74 (03) : 396 - 400
  • [48] Adenosquamous lung carcinoma: The importance of cyto-histologic correlation
    Felizardo, D.
    Cunha, A. L.
    Henrique, R.
    Lobo, C.
    VIRCHOWS ARCHIV, 2012, 461 : S75 - S76
  • [49] Surgical Outcomes and Prognostic Factors in the Treatment of Adenosquamous Carcinoma of the Lung
    Galetta, Domenico
    Borri, Alessandro
    Gasparri, Roberto
    Petrella, Francesco
    Spaggiari, Lorenzo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S745 - S745
  • [50] A clinicopathological and immunohistological re-evaluation of adenosquamous carcinoma of the lung
    Shimoji, Masaki
    Nakajima, Takashi
    Yamatani, Chihiro
    Yamamoto, Morio
    Saishou, Shinsuke
    Isaka, Mitsuhiro
    Maniwa, Tomohiro
    Ode, Yasuhisa
    Nakagawa, Kazuo
    Okumura, Takehiro
    Watanabe, Reiko
    Ito, Ichiro
    Kameya, Toru
    Endo, Masahiro
    Kondo, Haruhiko
    PATHOLOGY INTERNATIONAL, 2011, 61 (12) : 717 - 722